Endocrine sequelae of immune checkpoint inhibitors
G Ntali, E Kassi, M Alevizaki - Hormones, 2017 - Springer
Cancer immunotherapy has introduced a novel class of drugs known as immune checkpoint
inhibitors (ICIs). They enhance antitumour immunity by blocking negative regulators …
inhibitors (ICIs). They enhance antitumour immunity by blocking negative regulators …
[HTML][HTML] Cancer immunotherapy: unique perspectives for endocrine-related cancers
The landscape of therapeutic options for patients with cancer has changed dramatically in
the last decade. Advances in understanding the role of driver mutations in mediating tumor …
the last decade. Advances in understanding the role of driver mutations in mediating tumor …